[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550697":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":31,"centralContacts":31,"locations":32,"responsibleParty":189,"collaborators":31,"id":191,"slug":31,"hasResults":192,"nctId":193,"briefTitle":194,"officialTitle":195,"acronym":196,"eligibilityCriteria":197,"healthyVolunteers":192,"sex":198,"minAge":199,"maxAge":200,"enrollmentInfo":201,"targetDuration":31,"studyType":204,"phases":205,"briefSummary":207,"conditions":208,"keywords":31,"overallStatus":58,"whyStopped":31,"lastUpdateSubmitDate":211,"lastUpdatePostDateStruct":212,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":219,"locationsCount":220},{"fullName":5,"class":6},"Salvia BioElectronics","INDUSTRY",[8,14,19,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1 - Treatment Group","EXPERIMENTAL","Active therapy modality",[13],"Device: PRIMUS",{"label":15,"type":16,"description":17,"interventionNames":18},"Cohort 1 - Control Group","OTHER","Sham therapy",[13],{"label":20,"type":10,"description":11,"interventionNames":21},"Cohort 2 - Therapy V",[13],{"label":23,"type":10,"description":11,"interventionNames":24},"Cohort 2 - Therapy D",[13],[26],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DEVICE","PRIMUS","The Salvia PRIMUS System is designed to provide subcutaneous neurostimulation to the branches of the trigeminal and occipital nerves.",[15,9,23,20],null,[33,46,56,73,88,97,118,131,144,157,174],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":31},"Genesis Research Services","ACTIVE_NOT_RECRUITING","Broadmeadow","New South Wales","NSW, 2292","Australia",{"type":41,"coordinates":42},"Point",[43,44],151.72849,-32.92371,{"lat":44,"lon":43},{"facility":47,"status":35,"city":48,"state":49,"zip":50,"country":39,"cosmosGeoPoint":51,"geoPoint":55,"contacts":31},"Resolve Pain","Buderim","Queensland","4556",{"type":41,"coordinates":52},[53,54],153.05705,-26.68443,{"lat":54,"lon":53},{"facility":57,"status":58,"city":59,"state":60,"zip":31,"country":61,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"ZAS Antwerpen, Campus Sint-Augustinus","RECRUITING","Wilrijk","Antwerpen","Belgium",{"type":41,"coordinates":63},[64,65],4.39513,51.16734,{"lat":65,"lon":64},[68],{"name":69,"role":70,"phone":71,"phoneExt":31,"email":72},"Kelderman, Dr.","CONTACT","+32 03 285 28 50","tim.kelderman@zas.be",{"facility":74,"status":58,"city":75,"state":76,"zip":77,"country":61,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Jessa Hasselt","Hasselt","Limburg","3500",{"type":41,"coordinates":79},[80,81],5.33781,50.93106,{"lat":81,"lon":80},[84],{"name":85,"role":70,"phone":86,"phoneExt":31,"email":87},"Plazier, Prof. Dr.","+32 (0)11 33 75 70","Mark.Plazier@jessazh.be",{"facility":89,"status":35,"city":90,"state":91,"zip":31,"country":61,"cosmosGeoPoint":92,"geoPoint":96,"contacts":31},"Private Practice Dr. Sava","Saint-Nicolas","Liège",{"type":41,"coordinates":93},[94,95],5.53243,50.62837,{"lat":95,"lon":94},{"facility":98,"status":58,"city":99,"state":100,"zip":101,"country":61,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"AZ Sint Jan Brugge","Bruges","West Vlaanderen","8000",{"type":41,"coordinates":103},[104,105],3.22424,51.20892,{"lat":105,"lon":104},[108,112,115],{"name":109,"role":70,"phone":110,"phoneExt":31,"email":111},"Study Coordinator","+32 50 45 36 96","Liesbeth.Laloo@azsintjan.be",{"name":113,"role":114,"phone":31,"phoneExt":31,"email":31},"Dr. Van Dycke","PRINCIPAL_INVESTIGATOR",{"name":116,"role":117,"phone":31,"phoneExt":31,"email":31},"Dr. Vandenbussche","SUB_INVESTIGATOR",{"facility":119,"status":58,"city":120,"state":100,"zip":31,"country":61,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"AZ Groeninge","Kortrijk",{"type":41,"coordinates":122},[123,124],3.26487,50.82803,{"lat":124,"lon":123},[127],{"name":128,"role":70,"phone":129,"phoneExt":31,"email":130},"Dr. Vanhee","+32 56 63 34 20","neurologie@azgroeninge.be",{"facility":132,"status":58,"city":133,"state":100,"zip":31,"country":61,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"AZ Oostende","Ostend",{"type":41,"coordinates":135},[136,137],2.927,51.21551,{"lat":137,"lon":136},[140],{"name":141,"role":70,"phone":142,"phoneExt":31,"email":143},"Dr. De Pauw","+32 59 41 40 60","neurologie.damiaan@azoostende.be",{"facility":145,"status":58,"city":146,"state":100,"zip":31,"country":61,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"AZ Delta","Roeselare",{"type":41,"coordinates":148},[149,150],3.12269,50.94653,{"lat":150,"lon":149},[153],{"name":154,"role":70,"phone":155,"phoneExt":31,"email":156},"Billet, Dr.","051 23 69 12","ctc.pijn@azdelta.be",{"facility":158,"status":58,"city":159,"state":31,"zip":31,"country":160,"cosmosGeoPoint":161,"geoPoint":165,"contacts":166},"St. Antonius Nieuwegein","Nieuwegein","Netherlands",{"type":41,"coordinates":162},[163,164],5.08056,52.02917,{"lat":164,"lon":163},[167,170,172],{"name":109,"role":70,"phone":168,"phoneExt":31,"email":169},"088 320 88 59","i.lange@antoniusziekenhuis.nl",{"name":171,"role":114,"phone":31,"phoneExt":31,"email":31},"Dr. Nijhuis",{"name":173,"role":117,"phone":31,"phoneExt":31,"email":31},"Dr. Hilkens",{"facility":175,"status":58,"city":176,"state":31,"zip":31,"country":160,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Erasmus MC Rotterdam","Rotterdam",{"type":41,"coordinates":178},[179,180],4.47917,51.9225,{"lat":180,"lon":179},[183,187],{"name":184,"role":70,"phone":185,"phoneExt":31,"email":186},"Dr. Siepman","06 22331104","t.siepman@erasmusmc.nl",{"name":188,"role":114,"phone":31,"phoneExt":31,"email":31},"Prof. Huygen",{"type":190,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR","100550697",false,"NCT06450444","The RECLAIM Study.","Randomized, Double-blind, Controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. The RECLAIM Study.","RECLAIM","Inclusion Criteria:\n\n* Diagnosis of migraine as defined by the ICHD-3 Classification (with or without aura) with a history of chronic or high-frequency episodic migraine for at least 1 year prior to screening\n* Failure of 3 or more preventive pharmacological therapies\n* Stable on preventive migraine treatments\n* Psychologically stable\n\nExclusion Criteria:\n\n* Concomitant invasive or non-invasive neuromodulation\n* Previous exposure to an implantable neuromodulation device for headache\n* Have an existing active implantable medical device nearby the implant location (e.g. DBS, cochlear implant)\n* Use of onabotulinum toxin A injections for the treatment of migraine in the past 3 months.\n* Use of local corticosteroid injections in the occipital or supra-orbital region in the past 3 months prior to enrollment.\n* Not pregnant, nursing or not using contraception","ALL","18 Years","84 Years",{"count":202,"type":203},110,"ESTIMATED","INTERVENTIONAL",[206],"NA","The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.",[209,210],"Chronic Migraine","High Frequency Episodic Migraine","2026-03-26",{"date":213,"type":214},"2026-03-27","ACTUAL",{"date":216,"type":214},"2024-06-24",{"date":218,"type":203},"2029-01-31",{"name":5,"class":6},11]